ABL Bio Inc (298380) — Cash Flow Reinvestment Rate
ABL Bio Inc (298380) has a Cash Flow Reinvestment Rate of 0.04x as of March 2026, reinvesting ₩1.29 Billion (capex ₩243.74 Million plus investments ₩1.04 Billion) from operating cash flow of ₩32.84 Billion. Check ABL Bio Inc (298380) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ABL Bio Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for ABL Bio Inc across 1 annual periods. Explore ABL Bio Inc (298380) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for ABL Bio Inc (2022–2022)
Year-by-year capital reinvestment analysis for ABL Bio Inc. For live market cap and broader valuation context, see ABL Bio Inc (298380) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.67x | ₩48.29 Billion | ₩72.13 Billion | ₩2.06 Billion | — |